Clinical Trial: A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Advanced Solid Tumor (Phase 1)
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2a Study of IMM-6-415 in Participants With Advanced or Metastatic Malignancies Harboring RAS or RAF Oncogenic Mutations
Brief Summary:
This is a FIH, ascending dose study to characterize the safety, tolerability, optimal dose and preliminary anti-tumor activity of IMM-6-415 in participants with advanced or metastatic solid tumors harboring RAS or RAF oncogenic mutations.
Read more